Skip to main content

Treatment Clinical Trials for Small Intestinal Cancer

Review the small intestinal cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-11 of 11

Nanoliposomal Irinotecan plus Oxaliplatin with Fluorouracil and Folinic Acid for the Treatment of Unresectable or Metastatic Small Bowel Cancer
Status: Active
Location: 4 locations
Local Ablative Therapy for the Treatment of Oligo-progressive Gastrointestinal Cancers, The LIVELONG Trial
Status: Active
Location: 4 locations
D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Status: Active
Location: 2 locations
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients with Pancreatic Cancer That Can Be Removed by Surgery
Status: Active
Location: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
Sequential Cytoreductive Interventions for the Treatment of Patients with Metastatic Digestive System Adenocarcinoma with Undetectable ctDNA
Status: Active
Location: Yale University, New Haven, Connecticut
A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Cancer Vaccines (Ad5.F35-hGUCY2C-PADRE and Lm-GUCY2C) for the Treatment of Locally Advanced or Metastatic Colorectal and Small Bowel Cancer
Status: Active
Location: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
gFOLFOXIRITAX Regimen for the Treatment of Locally Advanced or Metastatic Upper Gastrointestinal Adenocarcinoma, I-FLOAT Study
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Pressurized Intraperitoneal Aerosol Chemotherapy with Mitomycin C for the Treatment of Peritoneal Carcinomatosis from Gastrointestinal Cancers
Status: Approved
Location: Moffitt Cancer Center, Tampa, Florida
Cell Therapy (Tumor Infiltrating Lymphocytes) and Aldesleukin in Treating Patients with Locally Advanced, Recurrent, Refractory, or Metastatic Biliary Tract Cancers
Status: Temporarily Closed to Accrual
Location: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
DNX-2440 for Resectable Colorectal Liver Metastasis
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov